Table 3.
Characteristics associated with each treatment group for advanced kidney disease (n=28,568)
| Characteristics at Cohort Entry | aORa (95% CI) | ||
|---|---|---|---|
| Received Dialysis by Chart Review | Discussing or Preparing for Dialysis | Decision against Dialysis | |
| Age, yr | |||
| <65 | Reference | Reference | Reference |
| 65–74 | 1.65 (1.29 to 2.11) | 1.32 (1.07 to 1.63) | 2.08 (1.65 to 2.63) |
| ≥75 | 1.44 (1.11 to 1.86) | 1.46 (1.19 to 1.80) | 5.83 (4.74 to 7.17) |
| Race | |||
| White | Reference | Reference | Reference |
| Black | 0.98 (0.77 to 1.24) | 0.81 (0.66 to 0.99) | 0.70 (0.58 to 0.84) |
| Other | 2.87 (2.20 to 3.76) | 2.98 (2.40 to 3.70) | 2.17 (1.74 to 2.72) |
| Sex, men (versus women) | 1.47 (0.54 to 4.01) | 1.14 (0.56 to 2.35) | 1.00 (0.50 to 2.02) |
| Burden of comorbidity | |||
| Low | Reference | Reference | Reference |
| Moderate | 1.99 (1.51 to 2.64) | 1.35 (1.10 to 1.66) | 1.54 (1.26 to 1.89) |
| High | 3.38 (2.43 to 4.71) | 1.64 (1.25 to 2.15) | 3.07 (2.42 to 3.90) |
| Comorbidities | |||
| Hypertension | 0.84 (0.56 to 1.26) | 0.75 (0.54 to 1.04) | 0.54 (0.42 to 0.70) |
| Coronary artery disease | 1.13 (0.90 to 1.40) | 1.15 (0.96 to 1.38) | 0.86 (0.73 to 1.01) |
| Congestive heart failure | 1.19 (0.94 to 1.52) | 0.98 (0.80 to 1.21) | 1.03 (0.86 to 1.23) |
| Diabetes mellitus | 0.68 (0.55 to 0.84) | 0.64 (0.54 to 0.76) | 0.78 (0.67 to 0.91) |
| Peripheral artery disease | 1.01 (0.77 to 1.32) | 1.01 (0.80 to 1.28) | 0.94 (0.77 to 1.15) |
| Cancer | 1.28 (1.01 to 1.630 | 1.50 (1.23 to 1.82) | 1.40 (1.19 to 1.65) |
| Chronic obstructive pulmonary disease | 1.47 (1.17 to 1.86) | 1.42 (1.16 to 1.75) | 1.33 (1.11 to 1.58) |
| Dementia | 1.99 (1.18 to 3.36) | 1.68 (1.03 to 2.76) | 3.41 (2.53 to 4.60) |
| Stroke | 0.71 (0.48 to 1.03) | 1.16 (0.88 to 1.52) | 1.40 (1.11 to 1.75) |
| Cirrhosis | 2.98 (1.78 to 4.97) | 1.84 (1.07 to 3.15) | 1.91 (1.11 to 3.29) |
| ≥4 (versus <4) Nephrology clinic visits in year prior | 0.40 (0.32 to 0.50) | 0.54 (0.45 to 0.65) | 0.32 (0.26 to 1.09) |
Multinomial logistic regression model adjusted for age, race, sex, comorbidity burden, comorbidities, prior nephrology care, and year of cohort entry. aOR, adjusted odds ratio; 95% CI, 95% confidence interval.
a
Reference group includes patients who were enrolled in the US Renal Data System or had a dialysis procedure code in Medicare or Department of Veteran Affairs administrative files.